PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
73.69
+9.20 (14.27%)
At close: May 8, 2026, 4:00 PM EDT
73.68
-0.01 (-0.01%)
After-hours: May 8, 2026, 6:10 PM EDT

PTC Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,1136,1893,5082,0872,7902,821
Market Cap Growth
56.41%76.44%68.11%-25.22%-1.09%-33.70%
Enterprise Value
6,9424,3402,7441,6093,0712,423
Last Close Price
73.6975.9645.1427.5638.1739.83
PE Ratio
-9.76-9.54-3.29-4.90-5.36
PS Ratio
7.393.584.352.223.995.24
PB Ratio
--30.14-3.19-2.55-8.042063.60
P/TBV Ratio
-33.53-32.67-3.16-2.52-7.892053.06
P/FCF Ratio
-8.81-30.72-11.17-7.18-10.09
P/OCF Ratio
-8.70-32.57-13.17-7.82-11.22
EV/Sales Ratio
8.392.513.401.724.394.50
EV/EBITDA Ratio
-4.79-12.09-7.93-9.64-7.81
EV/EBIT Ratio
-5.01-9.07-3.66-6.86-6.47
EV/FCF Ratio
-6.18-24.03-8.61-7.90-8.67
Debt / Equity Ratio
-0.50-0.47-0.34-0.49-1.99274.72
Debt / EBITDA Ratio
-34.890.44-1.72-2.04-2.21-1.72
Debt / FCF Ratio
-1.750.57-3.41-2.22-1.81-1.91
Net Debt / Equity Ratio
8.307.530.680.56-0.84-174.09
Net Debt / EBITDA Ratio
132.23-1.713.312.28-0.920.77
Net Debt / FCF Ratio
6.62-2.206.572.47-0.750.85
Asset Turnover
0.290.750.450.520.380.26
Inventory Turnover
0.800.912.132.502.371.87
Quick Ratio
2.292.202.231.721.391.74
Current Ratio
2.442.352.352.021.711.87
Return on Equity (ROE)
96.81%-104.75%37.91%107.51%323.39%-216.78%
Return on Assets (ROA)
-1.60%36.91%-16.81%-21.97%-23.37%-18.26%
Return on Invested Capital (ROIC)
-7.48%203.93%-68.18%-49.41%-46.01%-43.54%
Return on Capital Employed (ROCE)
-3.01%56.77%-25.04%-33.91%-32.80%-22.29%
Earnings Yield
-3.05%10.24%-10.48%-30.37%-20.41%-18.65%
FCF Yield
-3.70%11.35%-3.26%-8.96%-13.93%-9.91%
Buyback Yield / Dilution
-1.66%-14.92%-2.68%-4.34%-1.79%-6.72%
Total Shareholder Return
-1.66%-14.92%-2.68%-4.34%-1.79%-6.72%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q